Cargando…
Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
Low serum levels of 1α, 25-dihydroxyvitamin D3 (VD3) are associated with a higher mortality in trauma patients with sepsis or ARDS. However, the molecular mechanisms behind this observation are not yet understood. VD(3) is known to stimulate lung maturity, alveolar type II cell differentiation, or p...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138495/ https://www.ncbi.nlm.nih.gov/pubmed/37108455 http://dx.doi.org/10.3390/ijms24087298 |
_version_ | 1785032720328425472 |
---|---|
author | Xiong, Junyu Kaleja, Patrick Ückert, Larissa Nezaratizadeh, Niloufar Krantz, Stefanie Krause, Martin Friedrich Fitschen-Oestern, Stefanie Seekamp, Andreas Cassidy, Liam Tholey, Andreas Fuchs, Sabine |
author_facet | Xiong, Junyu Kaleja, Patrick Ückert, Larissa Nezaratizadeh, Niloufar Krantz, Stefanie Krause, Martin Friedrich Fitschen-Oestern, Stefanie Seekamp, Andreas Cassidy, Liam Tholey, Andreas Fuchs, Sabine |
author_sort | Xiong, Junyu |
collection | PubMed |
description | Low serum levels of 1α, 25-dihydroxyvitamin D3 (VD3) are associated with a higher mortality in trauma patients with sepsis or ARDS. However, the molecular mechanisms behind this observation are not yet understood. VD(3) is known to stimulate lung maturity, alveolar type II cell differentiation, or pulmonary surfactant synthesis and guides epithelial defense during infection. In this study, we investigated the impact of VD(3) on the alveolar–capillary barrier in a co-culture model of alveolar epithelial cells and microvascular endothelial cells respectively in the individual cell types. After stimulation with bacterial LPS (lipopolysaccharide), gene expression of inflammatory cytokines, surfactant proteins, transport proteins, antimicrobial peptide, and doublecortin-like kinase 1 (DCLK1) were analyzed by real-time PCR, while corresponding proteins were evaluated by ELISA, immune-fluorescence, or Western blot. The effect of VD3 on the intracellular protein composition in H441 cells was analyzed by quantitative liquid chromatography-mass spectrometry-based proteomics. VD(3) effectively protected the alveolar–capillary barrier against LPS treatment, as indicated by TEER measurement and morphological assessment. VD(3) did not inhibit the IL-6 secretion by H441 and OEC but restricted the diffusion of IL-6 to the epithelial compartment. Further, VD(3) could significantly suppress the surfactant protein A expression induced in the co-culture system by LPS treatment. VD(3) induced high levels of the antimicrobial peptide LL-37, which counteracted effects by LPS and strengthened the barrier. Quantitative proteomics identified VD3-dependent protein abundance changes ranging from constitutional extracellular matrix components and surfactant-associated proteins to immune-regulatory molecules. DCLK1, as a newly described target molecule for VD(3), was prominently stimulated by VD(3) (10 nM) and seems to influence the alveolar–epithelial cell barrier and regeneration. |
format | Online Article Text |
id | pubmed-10138495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101384952023-04-28 Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 Xiong, Junyu Kaleja, Patrick Ückert, Larissa Nezaratizadeh, Niloufar Krantz, Stefanie Krause, Martin Friedrich Fitschen-Oestern, Stefanie Seekamp, Andreas Cassidy, Liam Tholey, Andreas Fuchs, Sabine Int J Mol Sci Article Low serum levels of 1α, 25-dihydroxyvitamin D3 (VD3) are associated with a higher mortality in trauma patients with sepsis or ARDS. However, the molecular mechanisms behind this observation are not yet understood. VD(3) is known to stimulate lung maturity, alveolar type II cell differentiation, or pulmonary surfactant synthesis and guides epithelial defense during infection. In this study, we investigated the impact of VD(3) on the alveolar–capillary barrier in a co-culture model of alveolar epithelial cells and microvascular endothelial cells respectively in the individual cell types. After stimulation with bacterial LPS (lipopolysaccharide), gene expression of inflammatory cytokines, surfactant proteins, transport proteins, antimicrobial peptide, and doublecortin-like kinase 1 (DCLK1) were analyzed by real-time PCR, while corresponding proteins were evaluated by ELISA, immune-fluorescence, or Western blot. The effect of VD3 on the intracellular protein composition in H441 cells was analyzed by quantitative liquid chromatography-mass spectrometry-based proteomics. VD(3) effectively protected the alveolar–capillary barrier against LPS treatment, as indicated by TEER measurement and morphological assessment. VD(3) did not inhibit the IL-6 secretion by H441 and OEC but restricted the diffusion of IL-6 to the epithelial compartment. Further, VD(3) could significantly suppress the surfactant protein A expression induced in the co-culture system by LPS treatment. VD(3) induced high levels of the antimicrobial peptide LL-37, which counteracted effects by LPS and strengthened the barrier. Quantitative proteomics identified VD3-dependent protein abundance changes ranging from constitutional extracellular matrix components and surfactant-associated proteins to immune-regulatory molecules. DCLK1, as a newly described target molecule for VD(3), was prominently stimulated by VD(3) (10 nM) and seems to influence the alveolar–epithelial cell barrier and regeneration. MDPI 2023-04-14 /pmc/articles/PMC10138495/ /pubmed/37108455 http://dx.doi.org/10.3390/ijms24087298 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Xiong, Junyu Kaleja, Patrick Ückert, Larissa Nezaratizadeh, Niloufar Krantz, Stefanie Krause, Martin Friedrich Fitschen-Oestern, Stefanie Seekamp, Andreas Cassidy, Liam Tholey, Andreas Fuchs, Sabine Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 |
title | Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 |
title_full | Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 |
title_fullStr | Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 |
title_full_unstemmed | Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 |
title_short | Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 |
title_sort | alveolar–capillary barrier protection in vitro: lung cell type-specific effects and molecular mechanisms induced by 1α, 25-dihydroxyvitamin d3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138495/ https://www.ncbi.nlm.nih.gov/pubmed/37108455 http://dx.doi.org/10.3390/ijms24087298 |
work_keys_str_mv | AT xiongjunyu alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT kalejapatrick alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT uckertlarissa alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT nezaratizadehniloufar alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT krantzstefanie alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT krausemartinfriedrich alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT fitschenoesternstefanie alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT seekampandreas alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT cassidyliam alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT tholeyandreas alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 AT fuchssabine alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3 |